Video Experimental Relacionado
Updated: Jul 17, 2026
08:47
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Evaluación y manejo de la disfunción renal en la insuficiencia cardíaca avanzada: una declaración científica de la
Circulation
|September 10, 2024
Resumen
La detección temprana de la disfunción renal en la insuficiencia cardíaca avanzada es vital. Esta declaración guía la evaluación, el manejo y los cuidados paliativos para la enfermedad renal en pacientes con insuficiencia cardíaca.
Área de la Ciencia:
- Cardiología
- Nefrología
- Médico interno
Sus antecedentes:
- La disfunción renal es común en la insuficiencia cardíaca avanzada, afectando los resultados del paciente.
- Más allá de la creatinina, la disfunción incluye desequilibrio líquido/electrolítico, retención de soluto urémico y trastornos endocrinos.
- Los cambios hemodinámicos y las respuestas neurohormonas pueden causar índices renales fluctuantes.
Objetivo del estudio:
- Proporcionar un marco para evaluar la disfunción renal en la insuficiencia cardíaca avanzada.
- Para delinear estrategias de manejo para la enfermedad renal a través de trayectorias de insuficiencia cardíaca, incluyendo terapias avanzadas.
- Abordar los cuidados paliativos y la toma de decisiones en pacientes con insuficiencia cardíaca avanzada y enfermedad renal coexistentes.
Principales métodos:
- Esta es una declaración científica que sintetiza el conocimiento actual.
- Se centra en los marcos de gestión y evaluación clínica.
- Revisa la atención preoperatoria, perioperatoria y postoperatoria para las terapias quirúrgicas y de reemplazo renal.
Principales resultados:
- Establece un marco conceptual para la evaluación de la disfunción renal en la insuficiencia cardíaca.
- Detalla los enfoques de tratamiento para la enfermedad renal en pacientes con insuficiencia cardíaca avanzada.
- Destaca el cuidado paliativo único y las consideraciones para la toma de decisiones.
Conclusiones:
- La evaluación precisa de la enfermedad renal intrínseca es clave para predecir la respuesta al tratamiento.
- El tratamiento integrado de la insuficiencia cardíaca y la enfermedad renal es esencial.
- Los cuidados paliativos juegan un papel crítico en las etapas avanzadas.
Videos de Conceptos Relacionados
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...